Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IMPDH1P6 stands for "Inosine monophosphate dehydrogenase 1 pseudogene 6." It is one of several pseudogenes related to the IMPDH1 enzyme in the human genome. Pseudogenes such as IMPDH1P6 do not encode functional proteins and generally arise from gene duplication or retrotransposition events; they carry sequence resemblance to the parent gene but lack essential regulatory or coding features for proper expression and function[3][5]. No known protein product, biological function, or disease involvement is documented for IMPDH1P6, and major biological and biomedical databases describe it only as a pseudogene. IMPDH1P6 should not be considered a valid molecular or therapeutic target and is not involved in any known disease pathway, function, or drug interaction. It is most accurately classified as a pseudogene with no reported biological significance[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inosine monophosphate dehydrogenase 1 pseudogene 6 (IMPDH1P6).